# Mechanism of Action of tACS for the Treatment of MDD

> **NCT03994081** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 20 (actual)

## Conditions studied

- Major Depressive Disorder
- MDD

## Interventions

- **DEVICE:** tACS
- **DEVICE:** Sham tACS

## Key facts

- **NCT ID:** NCT03994081
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-09
- **Primary completion:** 2023-06-02
- **Final completion:** 2023-06-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03994081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03994081, "Mechanism of Action of tACS for the Treatment of MDD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03994081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*